From: The determinants of susceptibility/resistance to adjuvant arthritis in rats
Effector pathways/response | Susceptibility/resistance (+/-) | Rat strains tested | References |
---|---|---|---|
MHC and non-MHC genes including particular quantitative trait loci influence arthritis susceptibility | +/- | Table 1 | |
Differential T-cell proliferative and/or cytokine response to Bhsp65, its arthritogenic epitope 180 to 188, or its regulatory C-terminal determinants | +/- | LEW/WKY/Wistar/F344 | |
Increased T-cell response to Rhsp65 and its regulatory epitopes | - | LEW/WKY | |
Anti-Bhsp65/Rhsp65 antibody response induced upon Mtb challenge | - | LEW/BN/WKY/F344/Wistar | |
Increased expression of hsp47 in the joints and enhanced anti-hsp47 antibodies in rats with arthritis | + | DA/AO | [45] |
Immune response to hsp71 | - | DA/AO/LEW | |
Migration into and retention within the target organ (joints) of arthritogenic leukocytes; the role of monocyte chemoattractant protein 1 and monocyte/macrophage chemotaxis | + | LEW/WKY | |
Increased reactive oxygen species contributing to arthritis resistance | - | DA/AO | [10] |
Blunted hypothalamic–pituitary–adrenal axis activity | + | LEW/F344/Wistar | |
Microbial flora in a conventional housing environment | - | F344/Wistar |